Compugen to Present at the Morgan Stanley 19th Annual Global Healthcare Conference

Rhea-AI Summary

Compugen Ltd. (NASDAQ: CGEN) will present at the Morgan Stanley 19th Annual Global Healthcare Conference on September 9, 2021, at 11:00 am ET. The presentation will be available via a live webcast on Compugen's website, with a replay accessible afterward.

Compugen is focused on cancer immunotherapy, with key products like COM701 and COM902 in Phase 1 studies. Based in Israel, the company utilizes predictive discovery platforms to create novel drug targets.

HOLON, Israel, Aug. 26, 2021 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN), a leader in predictive discovery and development of first-in-class therapeutics for cancer immunotherapy, today announced that management will present at the Morgan Stanley 19^th Annual Global Healthcare Conference (virtual), on Thursday, September 9, 2021 at 11:00 am ET.

A live webcast of the presentation will be available on the Investor Relations section of Compugen's website at www.cgen.com. A replay will be available following the live event.

About Compugen  

Compugen is a clinical-stage discovery and development company utilizing its broadly applicable, predictive computational discovery platforms to identify novel drug targets and develop therapeutics in the field of cancer immunotherapy. Compugen's lead product candidate, COM701, a first-in-class anti-PVRIG antibody, for the treatment of solid tumors, is undergoing Phase 1 studies as a single agent and in dual, and triple combination. COM902, Compugen's second fully owned clinical antibody targeting TIGIT, for the treatment of solid and hematological tumors, is undergoing Phase 1 studies as a single agent and in dual combination. Compugen's therapeutic pipeline also includes early-stage immuno-oncology programs focused largely on myeloid targets. Compugen is headquartered in Israel, with offices in South San Francisco, CA. Compugen's shares are listed on Nasdaq and the Tel Aviv Stock Exchange under the ticker symbol CGEN. For additional information, please visit Compugen's corporate website at www.cgen.com. 

Company contact:  
Yvonne Naughton, PhD  
Head of Investor Relations and Corporate Communications
Email: ir@cgen.com  
Tel: +1 (628) 241-0071  

Investor Relations contact:
John Mullaly
LifeSci Advisors, LLC
Email: jmullaly@lifesciadvisors.com  
Tel: +1 (617) 429-3548

 

View original content:https://www.prnewswire.com/news-releases/compugen-to-present-at-the-morgan-stanley-19th-annual-global-healthcare-conference-301363440.html

SOURCE Compugen Ltd.

FAQ

What is the date of Compugen's presentation at the Morgan Stanley Healthcare Conference?

Compugen's presentation is scheduled for September 9, 2021.

What time will Compugen's presentation take place?

The presentation will take place at 11:00 am ET.

How can I watch Compugen's presentation at the conference?

The presentation will be available through a live webcast on Compugen's website.

What are Compugen's lead product candidates?

Compugen's lead products are COM701 and COM902, both in Phase 1 studies.

Where is Compugen based?

Compugen is headquartered in Israel and has an office in South San Francisco, CA.

What is the stock symbol for Compugen?

The stock symbol for Compugen is CGEN.